Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document is a detailed medical reference on skin and genetic disorders.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Quercetin may help improve skin conditions in cats with Feline Atopic Skin Syndrome.

Nilotinib may cause gray hair to return to its original color.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Alopecia areata treatment varies, with no optimal method established yet.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Atopic dermatitis is common in developing countries, but many patients receive poor care due to inconsistent guidelines and lack of resources.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Pimecrolimus cream is not effective for treating alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.